HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jergens to buy Curel, SoftSense for $135 mil., purchase builds skin care portfolio.

This article was originally published in The Rose Sheet

Executive Summary

JERGENS CUREL BUY COMPLEMENTS EXISTING MOISTURIZERS WITH THERAPEUTIC BRAND that has "broad support among dermatologists" for its moisturizing benefits, according to Andrew Jergens. The purchase of the Curel body lotion from Bausch & Lomb rounds out Jergens' mass market cosmetics lotion presence with an ethically positioned product that has packaging featuring the caduceus emblem of the medical profession, encircled with the words "Dermatologist Recommended." Curel carries a price tag roughly twice that of the company's Jergens lotion brand. Andrew Jergens also markets facial cleansers and moisturizers under the Jergens and Biore umbrellas.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel